Management of IIH in this setting consists of administering standard therapy (acetazolamide, therapeutic lumbar punctures) alongside correction the underlying triggering factor.Careful tapering corticosteroid and early ophthalmologic evaluation are essential in patients with INS, even those in remission, who develop headache or visual symptoms during corticosteroid dose reduction .(Lorrot et al., 1999) .Early recognition and treatment of IIH are essential to prevent permanent vision loss.In the remainder of the report, we will also review the literature on steroid-tapering-induced IIH in INS, the differential diagnosis (especially compared to CVT or true hydrocephalus), and outline therapeutic approaches.Conclusion: Conclusion: Steroid taper-induced IIH is a rare but potential complication in the management of idiopathic nephrotic syndrome.In patients on corticosteroids who present with headache, vomiting, or papilledema, particularly during dose reduction, prompt evaluation for possible IIH is warranted.This case highlights the need for vigilance and a multidisciplinary approach to differentiate IIH from other causes of intracranial hypertension and to initiate timely treatment, thereby preventing visionthreatening complications.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Kaur et al. (Wed,) studied this question.